42 related articles for article (PubMed ID: 32335153)
1. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.
Chaumeil MM; Ozawa T; Park I; Scott K; James CD; Nelson SJ; Ronen SM
Neuroimage; 2012 Jan; 59(1):193-201. PubMed ID: 21807103
[TBL] [Abstract][Full Text] [Related]
2. Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel.
Ahmed M; Semreen AM; Giddey AD; Ramadan WS; El-Awady R; Soares NC; El-Huneidi W; Bustanji Y; Alqudah MAY; Alzoubi KH; Semreen MH
Ann Med; 2023; 55(2):2305308. PubMed ID: 38253025
[TBL] [Abstract][Full Text] [Related]
3. Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastoma.
Panovska D; Nazari P; Cole B; Creemers PJ; Derweduwe M; Solie L; Van Gassen S; Claeys A; Verbeke T; Cohen EF; Tolstorukov MY; Saeys Y; Van der Planken D; Bosisio FM; Put E; Bamps S; Clement PM; Verfaillie M; Sciot R; Ligon KL; De Vleeschouwer S; Antoranz A; De Smet F
Cell Mol Life Sci; 2023 May; 80(6):147. PubMed ID: 37171617
[TBL] [Abstract][Full Text] [Related]
4. An End-to-end
Lin KH; Zhu JJ; Smith JA; Kim Y; Jiang X
IEEE Int Conf Healthc Inform; 2023 Jun; 2023():738-745. PubMed ID: 38516034
[TBL] [Abstract][Full Text] [Related]
5. Application of Electrospun Drug-Loaded Nanofibers in Cancer Therapy.
Yang Y; Zhang R; Liang Z; Guo J; Chen B; Zhou S; Yu D
Polymers (Basel); 2024 Feb; 16(4):. PubMed ID: 38399882
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh.
Chehri B; Liu K; Vaseghi G; Seyfoori A; Akbari M
Cells; 2024 Feb; 13(4):. PubMed ID: 38391976
[TBL] [Abstract][Full Text] [Related]
7. Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents.
Pizzimenti C; Fiorentino V; Franchina M; Martini M; Giuffrè G; Lentini M; Silvestris N; Di Pietro M; Fadda G; Tuccari G; Ieni A
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174088
[TBL] [Abstract][Full Text] [Related]
8. Drug Delivery Systems for Localized Cancer Combination Therapy.
Woodring RN; Gurysh EG; Bachelder EM; Ainslie KM
ACS Appl Bio Mater; 2023 Mar; 6(3):934-950. PubMed ID: 36791273
[TBL] [Abstract][Full Text] [Related]
9. The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug resistance of recurrent glioblastoma: in situ and in vitro analyses.
Hussein D; Alsereihi R; Salwati AAA; Algehani R; Alhowity A; Al-Hejin AM; Schulten HJ; Baeesa S; Bangash M; Alghamdi F; Cross R; Al Zughaibi T; Saka M; Chaudhary A; Abuzenadah A
Cancer Cell Int; 2022 Dec; 22(1):387. PubMed ID: 36482387
[TBL] [Abstract][Full Text] [Related]
10. Intracranial In Situ Thermosensitive Hydrogel Delivery of Temozolomide Accomplished by PLGA-PEG-PLGA Triblock Copolymer Blending for GBM Treatment.
Gu W; Fan R; Quan J; Cheng Y; Wang S; Zhang H; Zheng A; Song S
Polymers (Basel); 2022 Aug; 14(16):. PubMed ID: 36015626
[TBL] [Abstract][Full Text] [Related]
11. Multimodal platform for assessing drug distribution and response in clinical trials.
Lopez BGC; Kohale IN; Du Z; Korsunsky I; Abdelmoula WM; Dai Y; Stopka SA; Gaglia G; Randall EC; Regan MS; Basu SS; Clark AR; Marin BM; Mladek AC; Burgenske DM; Agar JN; Supko JG; Grossman SA; Nabors LB; Raychaudhuri S; Ligon KL; Wen PY; Alexander B; Lee EQ; Santagata S; Sarkaria J; White FM; Agar NYR
Neuro Oncol; 2022 Jan; 24(1):64-77. PubMed ID: 34383057
[TBL] [Abstract][Full Text] [Related]
12. A Fast and Efficient Approach to Obtaining High-Purity Glioma Stem Cell Culture.
Han XX; Cai C; Yu LM; Wang M; Hu DY; Ren J; Zhang MH; Zhu LY; Zhang WH; Huang W; He H; Gao Z
Front Genet; 2021; 12():639858. PubMed ID: 34295351
[TBL] [Abstract][Full Text] [Related]
13. Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors.
Griffith JI; Rathi S; Zhang W; Zhang W; Drewes LR; Sarkaria JN; Elmquist WF
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33322488
[TBL] [Abstract][Full Text] [Related]
14. Synergistic drug combinations for a precision medicine approach to interstitial glioblastoma therapy.
Graham-Gurysh EG; Murthy AB; Moore KM; Hingtgen SD; Bachelder EM; Ainslie KM
J Control Release; 2020 Jul; 323():282-292. PubMed ID: 32335153
[TBL] [Abstract][Full Text] [Related]
15. Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma.
Graham-Gurysh EG; Moore KM; Schorzman AN; Lee T; Zamboni WC; Hingtgen SD; Bachelder EM; Ainslie KM
ACS Appl Mater Interfaces; 2020 Apr; 12(17):19345-19356. PubMed ID: 32252517
[TBL] [Abstract][Full Text] [Related]
16. Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.
Graham-Gurysh E; Moore KM; Satterlee AB; Sheets KT; Lin FC; Bachelder EM; Miller CR; Hingtgen SD; Ainslie KM
Mol Pharm; 2018 Mar; 15(3):1309-1318. PubMed ID: 29342360
[TBL] [Abstract][Full Text] [Related]
17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
18. Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma.
Pena ES; Graham-Gurysh EG; Bachelder EM; Ainslie KM
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884965
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
